EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin‐6 initiates muscle‐ and adipose tissue wasting in a novel C57BL/6 model of cancer‐associated cachexia

Isabella Pototschnig, Ursula Feiler, Clemens Diwoky, Paul W Vesely, Thomas Rauchenwald, Margret Paar, Latifa Bakiri, Laura Pajed, Peter Hofer, Karl Kashofer, Nyamdelger Sukhbaatar, Gabriele Schoiswohl und 7 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2023-02 · 14 (1) · 93-107

DOI: 10.1002/jcsm.13109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 09.11.2022. Verfasst von Isabella Pototschnig und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biosciences, University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Cachexia, Interleukin-6, Neoplasms. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Louis Jeantet Foundation, BioTechMed-Flagship Project 'Midas', aH2020-MSCA-ITN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer‐associated cachexia (CAC) is a wasting syndrome drastically reducing efficacy of chemotherapy and life expectancy of patients. CAC affects up to 80% of cancer patients, yet the mechanisms underlying the disease are not well understood and no approved disease‐specific medication exists. As a multiorgan disorder, CAC can only be studied on an organismal level. To cover the diverse aetiologies of CAC, researchers rely on the availability of a multifaceted pool of cancer models with varying degrees of cachexia symptoms. So far, no tumour model syngeneic to C57BL/6 mice exists that allows direct comparison between cachexigenic‐ and non‐cachexigenic tumours.

Methods

MCA207 and CHX207 fibrosarcoma cells were intramuscularly implanted into male or female, 10–11‐week‐old C57BL/6J mice. Tumour tissues were subjected to magnetic resonance imaging, immunohistochemical‐, and transcriptomic analysis. Mice were analysed for tumour growth, body weight and ‐composition, food‐ and water intake, locomotor activity, O 2 consumption, CO 2 production, circulating blood cells, metabolites, and tumourkines. Mice were sacrificed with same tumour weights in all groups. Adipose tissues were examined using high‐resolution respirometry, lipolysis measurements in vitro and ex vivo , and radioactive tracer studies in vivo . Gene expression was determined in adipose‐ and muscle tissues by quantitative PCR and Western blotting analyses. Muscles and cultured myotubes were analysed histologically and by immunofluorescence microscopy for myofibre cross sectional area and myofibre diameter, respectively. Interleukin‐6 ( Il‐6 ) was deleted from cancer cells using CRISPR/Cas9 mediated gene editing.

Results

CHX207, but not MCA207‐tumour‐bearing mice exhibited major clinical features of CAC, including systemic inflammation, increased plasma IL‐6 concentrations (190 pg/mL, P ≤ 0.0001), increased energy expenditure (+28%, P ≤ 0.01), adipose tissue loss (−47%, P ≤ 0.0001), skeletal muscle wasting (−18%, P ≤ 0.001), and body weight reduction (−13%, P ≤ 0.01) 13 days after cancer cell inoculation. Adipose tissue loss resulted from reduced lipid uptake and ‐synthesis combined with increased lipolysis but was not associated with elevated beta‐adrenergic signalling or adipose tissue browning. Muscle atrophy was evident by reduced myofibre cross sectional area (−21.8%, P ≤ 0.001), increased catabolic‐ and reduced anabolic signalling. Deletion of IL‐6 from CHX207 cancer cells completely protected CHX207 IL6KO ‐tumour‐bearing mice from CAC.

Conclusions

In this study, we present CHX207 fibrosarcoma cells as a novel tool to investigate the mediators and metabolic consequences of CAC in C57BL/6 mice in comparison to non‐cachectic MCA207‐tumour‐bearing mice. IL‐6 represents an essential trigger for CAC development in CHX207‐tumour‐bearing mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaInterleukin-6NeoplasmsAnimalsFemaleMaleMiceAdipose TissueFibrosarcomaMice, Inbred C57BLMuscle Fibers, SkeletalMuscular Atrophy

Stichwörter der Autor:innen

Adipose tissueC57BL/6CachexiaCancerInterleukin-6

Substanzen

Interleukin-6

Autor:innen und Institutionen

  • Institute of Molecular Biosciences, University of Graz, Graz, Austria.
  • Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Division of Physiological Chemistry, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria.
  • Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria.
  • Department of Pharmacology and Toxicology, University of Graz, Graz, Austria.

ORCID-Profile: Martina Schweiger

Förderung

  • Louis Jeantet Foundation
  • BioTechMed-Flagship Project 'Midas'
  • aH2020-MSCA-ITN
  • DK Molecular Enzymology
  • Medical University of Vienna
  • Leducq Foundation
  • University of Graz
  • Austrian Science Fund

Zitieren

APA

Pototschnig, I., Feiler, U., Diwoky, C., Vesely, P. W., Rauchenwald, T., Paar, M., Bakiri, L., Pajed, L., Hofer, P., Kashofer, K., Sukhbaatar, N., Schoiswohl, G., Weichhart, T., Hoefler, G., Bock, C., Pichler, M., Wagner, E. F., Zechner, R., & Schweiger, M. (2023). Interleukin‐6 initiates muscle‐ and adipose tissue wasting in a novel C57BL/6 model of cancer‐associated cachexia. Journal of Cachexia, Sarcopenia and Muscle, 14(1), 93-107. https://doi.org/10.1002/jcsm.13109

Vancouver

Pototschnig I, Feiler U, Diwoky C, Vesely PW, Rauchenwald T, Paar M, et al. Interleukin‐6 initiates muscle‐ and adipose tissue wasting in a novel C57BL/6 model of cancer‐associated cachexia. Journal of Cachexia, Sarcopenia and Muscle. 2023;14(1):93-107. doi:10.1002/jcsm.13109

BibTeX
@article{Pototschnig2023,
  author = {Pototschnig, Isabella and Feiler, Ursula and Diwoky, Clemens and Vesely, Paul W and Rauchenwald, Thomas and Paar, Margret and Bakiri, Latifa and Pajed, Laura and Hofer, Peter and Kashofer, Karl and Sukhbaatar, Nyamdelger and Schoiswohl, Gabriele and Weichhart, Thomas and Hoefler, Gerald and Bock, Christoph and Pichler, Martin and Wagner, Erwin F and Zechner, Rudolf and Schweiger, Martina},
  title = {Interleukin‐6 initiates muscle‐ and adipose tissue wasting in a novel C57BL/6 model of cancer‐associated cachexia},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2023},
  volume = {14},
  number = {1},
  pages = {93--107},
  doi = {10.1002/jcsm.13109}
}
Kostenlos starten →